Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00070317 · ClinicalTrials.gov registry record · NA
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
A NA study, sponsored by Gynecologic Oncology Group.
- Terminated
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT00070317: Clinical Trial NA study, sponsored by Gynecologic Oncology Group.
NCT00070317 is a NA study that was terminated before completion, run by Gynecologic Oncology Group. The registered enrollment target is 102 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00070317, a NA study, was terminated before completion, sponsored by Gynecologic Oncology Group.
- TERMINATED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
This clinical trial is studying how well lymph node mapping and sentinel lymph node identification work in finding lymph node metastases in patients with stage IB1 cervical cancer. Diagnostic procedures, such as lymph node mapping and sentinel lymph node identification, performed before and during surgery, may improve the ability to detect lymph node metastases in patients who have cervical cancer.
Primary Outcome
Sensitivity is defined as the proportion of patients who test as positive sentinel node among the patients who have lymph node metastases.
Interventions
- PROCEDURE Lymphangiography
- PROCEDURE Radionuclide Imaging
- PROCEDURE Lymph Node Mapping
- DRUG Isosulfan Blue
- DRUG Methylene Blue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2004-06 |
| Est. Completion | 2013-01 |
| Phase | NA |
Why NCT00070317 stopped before completion
NCT00070317 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 5 interventions - of which Lymphangiography is the first listed.
NCT00070317 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00070317 about?
NCT00070317 is a clinical study titled "Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer". This clinical trial is studying how well lymph node mapping and sentinel lymph node identification work in finding lymph node metastases in patients with stage IB1 cervical cancer. Diagnostic procedures, such as lymph node mapping and sentinel lymph node identification, performed before and during s...
What is the current status of trial NCT00070317?
This trial is currently terminated. It is a NA study. The enrollment target is 102 participants. The study started on 2004-06. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00070317?
The interventions under investigation include: Lymphangiography (PROCEDURE), Radionuclide Imaging (PROCEDURE), Lymph Node Mapping (PROCEDURE), Isosulfan Blue (DRUG), Methylene Blue (DRUG).
Who is sponsoring clinical trial NCT00070317?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00070317's enrollment target sits among peer trials
102 837th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia